Results 31 to 40 of about 168,427 (273)

Barriers to and Facilitators of Hepatitis B Vaccination among the Adult Population in Indonesia: A Mixed Methods Study

Vaccines, 2023
To reach the goals of the Global Hepatitis Elimination 2030 program, Indonesia is now preparing a new regulation for hepatitis B vaccinations for adult population.
Putri Bungsu Machmud, Amand Führer, Cornelia Gottschick, Rafael Mikolajczyk   +3 more
doaj   +1 more source

Hepatitis B vaccination [PDF]

BMJ, 2007
Hepatitis B virus is a substantial threat to global health, with 360 million people chronically infected and more than 500 000 deaths each year from fulminant hepatitis, cirrhosis, and liver cancer.1 2 After a call by the World Health Organization for the global introduction of vaccine prevention programmes by 1997,3 82% of countries in the world had ...
openaire   +4 more sources

Influences of obesity on the immunogenicity of Hepatitis B vaccine

Human Vaccines & Immunotherapeutics, 2017
Objective: Hepatitis B vaccine is regarded as the most effective method for the prevention of hepatitis B virus (HBV) infection. However, several factors such as age, body mass index and immunocompetent state have been reported to be associated with ...
Fang Liu, Zhirong Guo, Chen Dong
doaj   +1 more source

Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial

Althea Medical Journal, 2023
Background: In order to fulfil the requirements of the national immunization program and sustain the production capacity of the monovalent Hepatitis B vaccine, this study aimed to assess the safety and immunogenicity of the recombinant Hepatitis B ...
Eddy Fadlyana, Rodman Tarigan, Kusnandi Rusmil, Rini Mulia Sari, Cissy B Kartasmita, Behesti Zahra Mardiah, Muhammad Gilang Dwi Putra   +6 more
doaj   +1 more source

Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease [PDF]

, 2013
Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of ...
A Wasley, AE Fiore, B Hernandez, BL Innis, BW Sherman, Dhiraj Yadav, DT Lau, EB Keeffe, EB Keeffe, EE Mast, F Andre, H Pham, Jaideep Behari, JJ Ott, JN Zuckerman, John E. Tavis, JR Kramer, K Chamie, Kaitlyn Sweeney, Kavitha Thudi, LM Prevedello, MA Worns, PL Almasio, RJ Jacobs, RL Barclay, SH Woolf, W Szmuness, YF Liaw   +27 more
core   +5 more sources

Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis

Human Vaccines & Immunotherapeutics, 2018
Hepatitis A and B disease burden persists in the US. We assessed hepatitis A and hepatitis B vaccination series completion rates among 350,240 commercial/Medicare and 12,599 Medicaid enrollees aged ≥19 years.
Parinaz K. Ghaswalla, Brandon J. Patterson, Wendy Y. Cheng, Emilie Duchesneau, Monica Macheca, Mei Sheng Duh   +5 more
doaj   +1 more source

Timing of Hepatitis B Vaccine Birth Dose in Exposed Newborns, Southwest Ethiopia: A Cross-Sectional Study

SAGE Open Nursing, 2023
Introduction Hepatitis B virus disease is a global acute and chronic communicable disease. Mother-to-child transmission is the reason for high carrier rates.
Mebratu Demissie MSc, Haregwa Asnake Weldekidan MSc, Yirgalem Yosef MSc, Seboka Abebe Sori MSc, Daniel Tsega MSc, Hirut Dinku Jiru MSc, Aberash Beyene Derribow MSc, Mesfin Difer Tetema MSc, Gudeta Beriso Jima MSc, Fentahun Temene Zeleke MSc, Fikremariam Endeshew MSc, Seblework Abeje MSc   +11 more
doaj   +1 more source

Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants

Vaccines, 2022
Introduction: The World Health Organization (WHO) recommends all newborn infants receive the first dose of the hepatitis B vaccine within 24 h of birth irrespective of maternal hepatitis B carrier status.
Donna Lei, Taryn Miller, Jeremy Carr, Jim Buttery, Claudia A. Nold-Petry, Marcel F. Nold, Atul Malhotra   +6 more
doaj   +1 more source

Occult hepatitis B infection among vaccinated cohort [PDF]

, 2013
BACKGROUND: Occult hepatitis B is characterized by undetectable levels of surface antigen, but detectable levels of viral DNA and is becoming a major global threat due to: (i) the effect on the health of children born to carrier mothers despite the ...
A. Malik, Yasmin, Mohammed Harmal, Nabil Saad, Mohd Taib, Niazlin, Sekawi, Zamberi, Shuaibu, Hudu Abdullahi   +4 more
core   +1 more source

Finding the key to solving problems in the hepatitis kingdom: A Study on the Development of Hepatitis B Vaccine by Kim Chung Young in the 1960-70s [PDF]

Uisahak, 2020
This paper analyzes the research process of Kim Chung Yong (henceforth referred to as KIM), who presented the hepatitis B vaccine in South Korea. In South Korea, which had been called the Hepatitis Kingdom, KIM developed a vaccine material for hepatitis ...
Miyoung SHIN
doaj   +1 more source